Vaccines that are designed for use only in developing countries face regulatory hurdles that may restrict their use. There are two primary reasons for this: most regulatory authorities are set up to address regulation of products for use only within their jurisdictions and regulatory authorities in developing countries traditionally have been considered weak. Some options for regulatory pathway...

Immunization is a great success of preventive medicine. In the United States, most vaccine-preventable diseases of childhood are at or near record lows while the number of diseases preventable by vaccination has increased. These successes result from a comprehensive system that includes basic research; developing and testing vaccine candidates; a manufacturing base; a regulatory authority; deve...

This study evaluated the capacity of the medicine pricing mechanism of the National Medicines and Poisons Board (NMPB), the medicine regulatory agency of Sudan, in controlling prices of imported medicines. The study was conducted between July and September 2008 and data on the 50 most sold medicines in 2007 were obtained from the records of the regulatory authority and pharmacies in Khartoum; 1...

We conducted this study to investigate the magnitude of food adulteration during 1995-2011 and consumer awareness in Dhaka city. We reviewed results of food sample testing by Public Health Food Laboratory of Dhaka City Corporation, Bangladesh Standards and Testing Institution, Consumers Association of Bangladesh publications, reports from lay press, including those on mobile magistrate court op...

tries around the world have implemented a series of neoliberal policies aimed at redefining the role of the state in the economy. This trend has been particularly pronounced in infrastructure industries such as telecommunications, electricity, water, sanitation, and transportation, in which state-owned enterprises long enjoyed monopolies. “Market-oriented” reform in these industries has include...

The Energy Policy Act (EPAct) of 2005 gave the U.S. Nuclear Regulatory Commission (NRC) regulatory authority over certain naturally occurring and acceleratorproduced radioactive material (NARM). The NRC published its final rule implementing this authority in the Federal Register on October 1, 2007 (72 FR 55863). The final rule expanded the definition of “byproduct material” in NRC regulations a...